Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XueZhitong Capsule for hypertriglyceridemia
ChiCTR1900025854Phase 4Recruiting
- Sponsor
- Beijing University of Chinese Medicine East Hospital
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of xuezhitong jiaonang in hypertriglyceridemia and hyperlipidemia (3 arms), sponsored by Beijing University of Chinese Medicine East Hospital. Primary endpoint: Change rate of triglycerides. Started Oct 2016; status: recruiting.
02
Drugs
xuezhitong jiaonang
03
Conditions
hypertriglyceridemiahyperlipidemia
Beyond the preview
Go deeper on ChiCTR1900025854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025854.